Home » Posts tagged with » chronic kidney disease
AstraZeneca gets FDA breakthrough status for Farxiga in CKD
AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with chronic kidney disease (CKD), irrespective of type 2 diabetes (T2D). According to the US Centers for Disease Control and Prevention (CDC), chronic kidney disease is a serious, progressive condition defined […]
Business News Today
- Lendesk acquires digital mortgage origination provider Finmo Financial
- B&G Foods to acquire Crisco shortening brand from Smucker’s for $550m
- Carlyle Group acquires 27 distribution logistics assets in France and Germany
- LubeZone acquires mobile truck services provider All Star Truck Repair
- Diageo to acquire Chase Original Potato Vodka owner Chase Distillery
- Coca-Cola European Partners plans to acquire Coca-Cola Amatil for $6.6bn
- Verisem acquires new vegetable seed processing facility in Warden, WA
- GrubMarket acquires Los Angeles-based produce provider Best Fresh Produce
- Danone’s Nutricia acquires special needs business Real Food Blends
- Bluestar Alliance wins stalking horse bid for tween fashion brand Justice
